Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
18.3M
-
Shares change
-
+162K
-
Total reported value, excl. options
-
$58.6M
-
Value change
-
-$232K
-
Put/Call ratio
-
0.16
-
Number of buys
-
33
-
Number of sells
-
-21
-
Price
-
$3.20
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q3 2023
75 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q3 2023.
Apyx Medical Corp - Common Stock (APYX) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.3M shares
of 35M outstanding shares and own 52.38% of the company stock.
Largest 10 shareholders include Archon Capital Management LLC (3.45M shares), ROYCE & ASSOCIATES LP (2.01M shares), AIGH Capital Management LLC (1.9M shares), RTW INVESTMENTS, LP (1.78M shares), VANGUARD GROUP INC (1.48M shares), PURA VIDA INVESTMENTS, LLC (837K shares), Taylor Frigon Capital Management LLC (621K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), BlackRock Inc. (498K shares), and Worth Venture Partners, LLC (463K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.